first-quart perform guidanc rais ye guidanc
rais give confid long-term outlook
summari stock thought
wednesday januari report fiscal first-quart result line
revenu pre-announce came high end earn rang despit
absorb loss thank divest cynosur busi full-year
guidanc updat sort abl make apples-
to-appl analysi view compani guidanc remain three quarter
increas dollar growth rate call organ
revenu exclud blood screen ssi cynosur foreign exchang ep
rais full year even hit consensu first quarter
ye gymnast go think overal messag first
quarter good outlook remain posit still see upsid potenti variou
opportun includ revenu first-quart growth toughest
comp year full year guid believ cent
upsid divestitur cynosur factor pad
spending/conservat embed guidanc
street may obsess nuanc get point point term guidanc
provid bridg revenu ep broader messag one hope
wind get lost myopic obsess see compani clearli
path midsingle-digit revenu growth see strength across busi
unit ye given quarter one may bit better anoth overal product
posit remain great shape team creativ find way drive growth
product line extens geograph expans simpli improv execut
everyth go compani geograph expans believ
import alway bit nervou reli intern
growth harder analyz market trend outsid unit state thing pop
take investor surpris see reason think growth slow meaning
given vast market share dispar domest intern well attent
manag put global initi quarter fxn organ growth
indic off-set low-single-digit growth rate organ
return equiti ttm
develop manufactur medic imag system product emphasi women health
busi unit focus breast health diagnost gynecolog surgeri aesthet skelet health
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
step back look whole pictur thing unquestion improv busi
month ago continu see outlook stabl tilt posit exact sentenc
wrote last coupl earn call adjust time refer still ring true compani biggest
franchis continu shoulder load confid growth continu forese futur new product
help revenu growth plenti cash flow accret earn accret share buyback
addit valuat move forward earn ebitda multipl roughli time respect
remain reason though multipl expans occur upsid expect need come
discuss manag took opportun updat revenu ep guidanc creat new organ
report convent organ growth exclud recent divest cynosur busi well contribut
ssi non-core blood screen revenu fx headwind show bridg net take-away
revenu guidanc core outlook increas approxim million around basi point assum
cynosur revenu full year would grown low singl digit roughli million remain
part year
earn front believ like bit room upsid develop appear
conservativ contempl modest increment spend seemingli built belief
cynosur divestitur like accret oppos neutral remaind year
diagnost theme seen late continu play name strong result molecular diagnost
fxn impress cytolog perinat better trend expect go
forward molecular diagnost growth came real impact influenza
intern effort last quarter strong placement
util trend continu panther system
continu think panther instrument along fusion sidecar boost menu
intern expans abl drive least midsingle-digit growth next coupl year
updat revenu guidanc million midpointprior upsid rel midpoint cynosur estimate thru assum lsd growth full fx benefit bs increment revenu alreadi came ssi increment revenu alreadi came /- chang new cynosur full year ssi full year blood screen full year fx organ prior year organ impli organ growth organ growth exclud cynosur blood screen ssi updat ep guidancemidpointprior cynosur upsid share buy-back benefit increment impact buy-back addit spend william blair
two larg refer lab custom fold multi-year contract comment impact
menu expans stori intern placement take center stage
look ahead focus virolog opportun remain largest infecti diseas market
diagnost begin compet expect traction larg refer lab
viral load test believ instal base within variou hospit network fertil ground meaning
convers occur time
term long state diagnost area legaci product well infus
growth enter new segment dynam industri make lot sens see broaden
differ call point new technolog opportun valuat moder bit
breast health put solid quarter grow constant currenc difficult comparison growth
though ad superson imag cart-bas ultrasound technolog revenu contempl growth less
imag unit state though tougher comp came play overal
believ complet transform breast health busi last sever year transform broke
boom/bust gantri cycl investor becom myopic focus recent look forward continu
see long runway segment driven servic revenu larger gantri sale tuck-in acquisit
believ perform deal model bring superson imag new product penetr
domest market gantri lot share make intern coupl grow suit
intervent product help boost revenu midsingle-digit-plu grower multiquart period
surgic growth much better growth unit state fxn growth outsid unit
state revenu segment come outsid unit state manag cite product qualiti new
leadership new commerci model new product launch driver myosur grew healthi midteen quarter
via share gain novasur singl digit improv recent quarter gain custom
extraordinarili comb contenti market certainli like kind growth rate believ someth
midsingl digit like appropri go forward segment
risk consid includ on-going strength intern busi abil sourc integr new acquisit
competit dynam within diagnost gynecolog surgic
quarter reviewcurr actualcurr estimateprior year quarter thousand unless servic gross oper oper income/ expens earn incom tax effect net incom dilut share ep compani report william blair compani estimatesconsensu estim currentrevenu earn per factset consensusfav/ unfav variancefav/ unfav varianc william blair
revenu review segment current actualcurr estim thousand unless revenu segment report diagnosticscytolog molecular blood total breast healthbreast imag intervent breast solut nmtotal breast medic gyn skelet total compani report william blair compani estimatesep bridg estim actualep bridg prior yearour ep prior year favorable/ unfavor varianc favorable/ unfavor varianc sale sale gross gross oper oper incom incom share share actual actual william blair
chang model prior cynosur updat thousand unless notedprevi estimatechangecurr guidanceiniti gross margin product bp oper oper bp income/ expens earn incom tax effect bp net incom bp dilut share ep growth/ declin yoy revenu revenu org ep revenu chang gyn medic total sourc compani report william blair compani import disclosur
